Target intelligence / Profile preview

30S bacterial ribosomal subunit (30S subunit)

Target
30S subunit
Molecular classification
Ribosomal subunit, Ribonucleoprotein complex, Translation machinery component, Other
01

Overview

The 30S bacterial ribosomal subunit is the smaller component of the 70S prokaryotic ribosome and consists of a single 16S ribosomal RNA molecule and about 19–21 proteins[3][5][8]. It plays a central role in protein synthesis by binding to messenger RNA (mRNA) and facilitating correct pairing with transfer RNA (tRNA) anticodons, ensuring the accurate translation of genetic information (decoding)[1][3][5][8]. In translation initiation, the 30S subunit recognizes the mRNA's Shine-Dalgarno sequence, positions the start codon, and interacts with initiation factors, after which it assembles with the 50S large subunit to form the active 70S ribosome[3][5][7]. Many clinically important antibiotics, such as aminoglycosides and tetracycline, bind to the 30S subunit where they inhibit translation by inducing codon misreading or preventing subunit assembly[1][5][8]. Its structure and function are conserved among bacteria, making it one of the most important and well-validated targets in antibacterial therapy[1][5][8].

Other names
prokaryotic small ribosomal subunitsmall ribosomal subunit (bacterial)30S ribosomal subunit
02

Mechanism of action

Inhibition of translation by binding the 30S subunit and causing misreading of mRNA or blocking translocation; Prevention of tRNA binding or ribosome assembly

03

Biological functions

mRNA bindingDecoding (ensuring codon-anticodon accuracy)Protein synthesis initiationTranslation regulationInteraction with tRNA and mRNA
04

Disease associations

Infection (target of antibacterial drugs)Other
05

Safety considerations

Antibiotic resistance develops through mutations in the 30S subunit or methylation of rRNAPotential off-target toxicity by affecting mitochondrial ribosomes (in eukaryotes)
06

Interacting drugs

Streptomycin

5 more in the full profile.

Beyond the preview

Go deeper on 30S bacterial ribosomal subunit (30S subunit).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 30S bacterial ribosomal subunit (30S subunit).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call